8th May 2024

US Capital Global Securities Announces $50MM Equity Offering for Pharmaceutical Innovator, Bridge Therapeutics

Bridge is pleased to announce our engagement with US Capital Global Securities for a $50 million equity offering. We are excited to offer eligible investors a unique opportunity to participate in this equity offering. USCG’s expertise in facilitating growth-stage investments makes them an ideal partner for this endeavor.

For more information about Bridge Therapeutics please contact us today using the form below.